COMMUNIQUÉS West-GlobeNewswire

Nuvectra Completes 3,000 U.S. Algovita® SCS Implantations
06/12/2018
PLANO, Texas, Dec. 06, 2018 (GLOBE NEWSWIRE) -- Nuvectra Corporation (NASDAQ: NVTR), a neurostimulation medical device company, announced today that the Company’s Algovita ® Spinal Cord Stimulation (SCS) system has been [...]
Ovid Therapeutics Announces Plans to Move into a Phase 3 Trial in Pediatric Patients Based on End-of-Phase 2 Meeting for OV101 in Angelman Syndrome
06/12/2018
-- Single pivotal Phase 3 trial design, using once-daily dosing, may be sufficient for approval of OV101 in Angelman syndrome -- -- Trial initiation activities have begun for ELARA, an open-label extension study for [...]
Rhythm Pharmaceuticals to Host Key Opinion Leader Symposium on MC4R Pathway and Patient Experience with Rare Genetic Disorders of Obesity, Including Bardet-Biedl Syndrome
06/12/2018
BOSTON, Dec. 06, 2018 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM), a biopharmaceutical company focused on the development and commercialization of therapeutics for the treatment of rare genetic [...]
Avinger Announces Commercial Launch in Australia
06/12/2018
Pantheris Receives Regulatory Clearance and First Patients Treated Successfully with Pantheris in Australia REDWOOD CITY, Calif., Dec. 06, 2018 (GLOBE NEWSWIRE) -- Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical [...]
BioSig Technologies To Commence First–in-Human Studies at Mayo Clinic
06/12/2018
Leading Institution to Become the Second Center after TCAI to Launch the Studies with PURE EP System Santa Monica, CA, Dec. 06, 2018 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM), a medical device company [...]
Chembio’s French Partner AAZ-LMB Wins Prix Galien International for Best Medical Technology with autotest VIH®
06/12/2018
MEDFORD, N.Y., Dec. 06, 2018 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostics company focused on infectious diseases, today announced that its French HIV self-test [...]
VBI Vaccines Enters into License and Collaboration Agreement with Brii Biosciences for up to $129 Million plus Royalties to Develop a Functional Cure for Hepatitis B
06/12/2018
Upon closing, VBI received gross proceeds of $11 million, consisting of an upfront payment and an equity investment at $3.05 per share from Brii Biosciences VBI is eligible to receive an additional $117.5 million in [...]
Rexahn Pharmaceuticals Streamlines Operations and Provides Update on Pipeline
06/12/2018
ROCKVILLE, Md., Dec. 06, 2018 (GLOBE NEWSWIRE) -- Rexahn Pharmaceuticals, Inc. (NYSE American: RNN), a clinical stage biopharmaceutical company developing innovative therapies to improve patient outcomes in cancers that [...]
Diamond CBD Goes Funny In New CBD Educational Awareness Ad Campaign
06/12/2018
"I am THC, I am CBD" video shorts use humor and nostalgia to dispel myths about hemp-derived CBD MIAMI, Dec. 06, 2018 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- Diamond CBD Inc., wholly owned subsidiary of PotNetwork [...]
Uptick Newswire’s Stock Day Podcast Features Richard Van Kirk, Pro-Dex, Inc.’s CEO, to talk about the Growing Success of The Company and Plans to Keep up The Momentum
06/12/2018
PHOENIX, Dec. 06, 2018 (GLOBE NEWSWIRE) -- Uptick Newswire hosts Pro-Dex, Inc. (NASDAQ: PDEX) (the company) on their Stock Day Podcast. The Company specializes in the design, development, and manufacture of autoclavable [...]
NASA Deploys Medigus’ micro ScoutCam™ Miniature HD Camera During Robotic Refueling Mission
06/12/2018
- Advanced CMOS camera to be launched into space to help broaden satellite servicing capabilities - OMER, Israel, Dec. 06, 2018 (GLOBE NEWSWIRE) -- Medigus Ltd. (NASDAQ: MDGS) (TASE: MDGS), a medical device company [...]
Kiniksa Provides Update on U.S. FDA Review of Investigational New Drug Application for Mavrilimumab in Giant Cell Arteritis
06/12/2018
HAMILTON, Bermuda, Dec. 06, 2018 (GLOBE NEWSWIRE) -- Kiniksa Pharmaceuticals, Ltd. (Nasdaq: KNSA) (“Kiniksa”), a biopharmaceutical company with a pipeline consisting of five product candidates across various stages of [...]
NanoVibronix Announces Publication of Study Measuring the Effect of Surface Acoustic Waves on Bacterial Load and Preventing Catheter-Associated Urinary Tract Infections
06/12/2018
UroShield™ reduced Colony Forming Units (CFU) count from >100,000 to 10,000 CFU or less in 25 of 29 patients in the treatment group No reported infections in the treatment group versus 27% symptomatic treated [...]
Daré Bioscience, Inc. Announces Licensing and Global Rights to Novel Phase III Product Candidate for the Treatment of Bacterial Vaginosis
06/12/2018
Bacterial vaginosis affects nearly 20 million women in the U.S. every year SAN DIEGO, Dec. 06, 2018 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE), a leader in clinical-stage women’s health innovation, today [...]
LogicBio Therapeutics Appoints Richard Moscicki, M.D., and Michael Wyzga to Board of Directors
06/12/2018
CAMBRIDGE, Mass., Dec. 06, 2018 (GLOBE NEWSWIRE) -- LogicBio Therapeutics, Inc. (NASDAQ:LOGC), a genome editing company focused on developing medicines to durably treat rare diseases, today announced the appointment [...]
Arch Therapeutics Provided Corporate Update at the 11th Annual LD Micro Main Event
06/12/2018
Company highlighted US and EU regulatory filings and positive patent ruling in Japan FRAMINGHAM, Mass., Dec. 06, 2018 (GLOBE NEWSWIRE) -- Arch Therapeutics, Inc. (OTCQB: ARTH) ("Arch" or the "Company"), developer of [...]
Brain Scientific Announces Successful Commercialization & First Purchase Order Shipment Of NeuroCap
06/12/2018
NEW YORK, Dec. 06, 2018 (GLOBE NEWSWIRE) -- Brain Scientific Inc. (OTC:BRSF) (“Brain Scientific” or “Company”), a medical device company combining brain analysis software with wireless sensor technologies for [...]
Auris Medical Announces Acquisition of Orphan Drug Designation and Secures Rights to In-License Additional Patents Related to Betahistine
06/12/2018
Acquires Orphan Drug Designation for betahistine for the treatment of obesity associated with Prader-Willi syndrome (PWS) Signs letter of intent to in-license two US patents covering use of betahistine for the treatment [...]
Pain Therapeutics Announces Initiation of a Phase II Study in Alzheimer’s Disease
06/12/2018
AUSTIN, Texas, Dec. 06, 2018 (GLOBE NEWSWIRE) -- Pain Therapeutics, Inc. (Nasdaq: PTIE), a biopharmaceutical company, announced today the initiation of a Phase II study to evaluate PTI-125 as a potential first line [...]

Pages